The largest database of trusted experimental protocols

8 protocols using recombinant il 22

1

Blocking IL-22 Mitigates DNA Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal anti-IL-22 (Clone 8E11) blocking antibody was kindly provided by Genentech (South San Francisco, USA). Anti-IL-22 (150μg/mouse) or control IgG were injected 36h, 12h before and 12h after inducing DNA damage. For reconstitution, mice were injected with recombinant IL-22 (400ng/mouse, Peprotech) i.p. every 8h for three days prior to the damage induction and at 8h and 16h afterwards. Epithelial cells were isolated 24h after damage. For the stimulation of ATM expression, mice were injected with recombinant IL-22 (500 ng/mouse, Peprotech) i.p. 12h and 2h prior to epithelial isolation.
+ Open protocol
+ Expand
2

Blocking IL-22 Mitigates DNA Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal anti-IL-22 (Clone 8E11) blocking antibody was kindly provided by Genentech (South San Francisco, USA). Anti-IL-22 (150μg/mouse) or control IgG were injected 36h, 12h before and 12h after inducing DNA damage. For reconstitution, mice were injected with recombinant IL-22 (400ng/mouse, Peprotech) i.p. every 8h for three days prior to the damage induction and at 8h and 16h afterwards. Epithelial cells were isolated 24h after damage. For the stimulation of ATM expression, mice were injected with recombinant IL-22 (500 ng/mouse, Peprotech) i.p. 12h and 2h prior to epithelial isolation.
+ Open protocol
+ Expand
3

STAT3 Chromatin Immunoprecipitation in Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected 1 μg recombinant IL-22 (Peprotech) or PBS i.p. 1h prior to epithelial cell isolation. Epithelial cells were isolated as described above. Cells were resuspended in PBS and fixed with 0.75% paraformaldehyde. Fixation was stopped with glycine and cells were washed and lysed in 50mM Tris, 2.5mM EDTA, 0.1% NP-40 and 10 % Glycerol. Nuclei were lysed in 50mM Tris, 5mM EDTA and 0.25% SDS and subsequently sonicated in a Bioruptor Plus (Diagenode). Lysates were cleared by centrifugation and stored at -80°C. Protein-A-coated magnetic beads (Diagenode) were blocked with yeast tRNA (Life Technologies) and BSA (New England Biolab). Nuclear lysates were split in 10% input and 90% immunoprecipitation solutions. The latter was incubated with α-STAT3 (C-20; Santa Cruz Biotechnology) overnight rotating at 4°C. Protein-A coded magnetic beads were added and incubated for another 30min rotating at 4°C. Beads were purified and washed repeatedly. Bound DNA was eluted in 10mM TRIS, 1 mM EDTA and 2% SDS at 37°C for 15min. De-crosslinking was performed overnight at 65°C. RNA was removed by 1h incubation with RNAse A (Peqlab) at 37°C, followed by 1h incubation with Proteinase K (Peqlab) at 42°C. DNA was purified using PCR Purification Kit (Qiagen) according to the manufacturer’s instructions. All antibodies used are listed in Supplementary Information Table 2.
+ Open protocol
+ Expand
4

STAT3 Expression Analysis in HaCaT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed to determine STAT3 expression in vitro. HaCaT cells were treated with PBS, Dextran (20 μg/ml), ACT (20 μg/ml)or ACT-Dex NPs (20 µg ACT equiv./mL) for 12 h. Subsequently, the cells were further stimulated using recombinant IL-22 (PeproTech; 50 ng/ml) for an additional 1 h, and the cell lysate was prepared. After electrophoresis, proteins were electroeluted onto a polyvinylidenedifluoride (PVDF) membrane (Invitrogen, Carlsbad, USA). Antibodies: anti-pSTAT3 (Tyr705) (Cell Signaling, Beverly, USA), STAT3 (Cell Signaling), and anti-actin (Abcam, Cambridge, United Kingdom). For the visualization of the immunoreactive proteins, an enhanced chemiluminescence assay kit and a chemiluminescence imaging system (ChemiScope 6200T, ClinX, Shanghai, China) were used.
+ Open protocol
+ Expand
5

Anti-IL-22 Antibody and Recombinant IL-22 in Anemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal anti-IL-22 (Clone IL22JOP) blocking antibody and isotype control IgG2aκ (Clone eBR2a) were purchased from Thermo Fisher Scientific. Mice were administered anti-IL-22 (50 μg/mouse) or isotype intraperitoneally every 48 h until the conclusion of the experiment. For \recombinant IL-22 treatment, mice were injected with recombinant IL-22 (500 ng/mouse; PeproTech) intraperitoneally every 24 h until the conclusion of the experiment. Mice were administered these reagents at least five times before inducing PhZ-mediated anemia.
+ Open protocol
+ Expand
6

STAT3 Chromatin Immunoprecipitation in Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were injected 1 μg recombinant IL-22 (Peprotech) or PBS i.p. 1h prior to epithelial cell isolation. Epithelial cells were isolated as described above. Cells were resuspended in PBS and fixed with 0.75% paraformaldehyde. Fixation was stopped with glycine and cells were washed and lysed in 50mM Tris, 2.5mM EDTA, 0.1% NP-40 and 10 % Glycerol. Nuclei were lysed in 50mM Tris, 5mM EDTA and 0.25% SDS and subsequently sonicated in a Bioruptor Plus (Diagenode). Lysates were cleared by centrifugation and stored at -80°C. Protein-A-coated magnetic beads (Diagenode) were blocked with yeast tRNA (Life Technologies) and BSA (New England Biolab). Nuclear lysates were split in 10% input and 90% immunoprecipitation solutions. The latter was incubated with α-STAT3 (C-20; Santa Cruz Biotechnology) overnight rotating at 4°C. Protein-A coded magnetic beads were added and incubated for another 30min rotating at 4°C. Beads were purified and washed repeatedly. Bound DNA was eluted in 10mM TRIS, 1 mM EDTA and 2% SDS at 37°C for 15min. De-crosslinking was performed overnight at 65°C. RNA was removed by 1h incubation with RNAse A (Peqlab) at 37°C, followed by 1h incubation with Proteinase K (Peqlab) at 42°C. DNA was purified using PCR Purification Kit (Qiagen) according to the manufacturer’s instructions. All antibodies used are listed in Supplementary Information Table 2.
+ Open protocol
+ Expand
7

Measuring CXCL-9 in Stimulated HaCaT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HaCaT cells (a keratinocyte cell line) were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma) supplemented with 5% fetal bovine serum and 0.5% penicillin/streptomycin. HaCaT cells were stimulated with either recombinant IFNγ (1 ng/mL) (Peprotech) and or recombinant IL-22 (30 ng/mL) (Peprotech) or day 5 culture supernatants from FACS sorted anti-CD3/anti-CD28 with or without IL-21 activated naïve (CD3+ CD4+ CD45RA+CD27+) T cells and cultured for 12 h with Golgi-Stop™. For blocking experiments, antihuman IFNγ antibody (10 µg/mL) or antihuman/mouse IL-22 antibody (10 ng/mL) or their respective isotype controls (10 ng/mL) were used. Adherent HaCaT cells harvested with 0.25% trypsin- dthylenediaminetetraacetic acid (Gibco) and intracellular CXCL-9 production measured by flow cytometry as described above.
+ Open protocol
+ Expand
8

Anti-IL-22 Antibody and Recombinant IL-22 in Anemia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal anti-IL-22 (Clone IL22JOP) blocking antibody and isotype control IgG2aκ (Clone eBR2a) were purchased from Thermo Fisher Scientific. Mice were administered anti-IL-22 (50 μg/mouse) or isotype intraperitoneally every 48 h until the conclusion of the experiment. For \recombinant IL-22 treatment, mice were injected with recombinant IL-22 (500 ng/mouse; PeproTech) intraperitoneally every 24 h until the conclusion of the experiment. Mice were administered these reagents at least five times before inducing PhZ-mediated anemia.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!